I have 25 years of experience, and specialize in the field of IND/NDA drug development programs with specific knowledge in the areas of pharmacology, clinical trials operations, writing of phase 1-3 protocols and final reports, IND submissions to the Federal Drug Administration (FDA). I have testified 6 times on topics such as IND clinical plans, toxicity study reports.